[ad_1]
A conversation about this with Professor Aurelija Žvirblienė and Seimas member Jurgita Sejonienė on the TV3.lt program “Dienas pjūvis”.
The portal tv3.lt recalls that in the region of Galicia in the north of Spain, a massive vaccination of the population began this weekend. Spaniards are being vaccinated with AstraZeneca vaccines here, although some other regions of the country, such as several EU countries, have temporarily abandoned AstraZeneca vaccines while checking whether the vaccine can be linked to reports of post-vaccination blood clots in patients. in Austria. Furthermore, Norway issued a similar report on clots in four patients after vaccination with AstraZeneca last night.
However, Italy’s northern Piedmont region decided on Sunday to stop vaccination with AstraZeneca after a teacher died the day after vaccination, regional officials said.
The company, which is experiencing a series of reputational hits, says its vaccine is not related to clots. But there is also unfortunate news that AstraZeneca’s vaccine shortage in the EU is likely to sit not only in the first quarter, but also in the second quarter of this year.
AstraZeneca reports that the vaccine shortage in the Community is not being reduced by importing vaccines from factories in other parts of the world due to export restrictions. Cheaper and large-scale AstraZeneca vaccines are crucial to the vaccination program across the EU.
[ad_2]
